| Original language | English (US) |
|---|---|
| Pages (from-to) | 258-261 |
| Number of pages | 4 |
| Journal | The Journal of pediatrics |
| Volume | 117 |
| Issue number | 2 PART 1 |
| DOIs | |
| State | Published - Aug 1990 |
Bibliographical note
Funding Information:Serum immunoglobulin levels were determined in 13 patients with end-stage renal disease managed by PD and in Supported by National Institutes of Health grants Nos. DKO 8232-01 and DKO 07087 and by a grant from the National Kidney Foundation of the Upper Midwest. Presented in part at the Eighth Congress of the International Pediatric Nephrology Association, Toronto, Ontario, Canada, September 1989. Submitted for publication Nov. 8, 1989; accepted Feb. 1, 1990. Reprint requests: Clifford E. Kashtan, MD, University of Minnesota Medical School, Division of Pediatric Nephrology, Box 491 UMHC, 515 Delaware St., SE, Minneapolis, MN 55455. 9/22/19817 eight uremic patients not undergoing PD. The groups were comparable in age (7.45 ___ 6.25 vs 8.87 + 8.28 months; p value not significant), calorie and protein intake (112.6 +_ 11 kcal/kg and 2.78 _+ 0.46 gm/kg vs 113 + 20 and 2.11 _+ 0.45; p value not significant), height and weight standard deviation score (-1.96 +_ 1.22 and -1.98 _+ 1.17 vs -2.37 _+ 1.13 and -1.45 _+ 1.46), and estimated creatinine clearance (9.71 _+ 2.0 vs 9.46 ___ 5.66 ml/min/l.73 m2; p value not significant).8 The cause of renal failure was renal dysplasia or obstructive uropathy or both in 8 of 13 and 6 of 8 patients, respectively. Other diagnoses in the PD group included oxalosis (two patients), tubulointerstitial